2852
Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: a review of the literature and implications for practice.
 radiation myelopathy: Effect; high-dose busulfan: Treatment; melphalan: Treatment; high-dose: Treatment.Dosage; busulfan: Treatment.Drug; melphalan: Treatment.Drug; Ewing's sarcoma:: Treatment.Disorder; busulfan: Combination.Drug; melphalan: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 radiation myelopathy: Effect; high-dose busulfan: Treatment; melphalan: Treatment; high-dose: Treatment.Dosage; busulfan: Treatment.Drug; melphalan: Treatment.Drug; Ewing's sarcoma:: Treatment.Disorder; busulfan: Combination.Drug; melphalan: Combination.Drug